R R Bahnson
Overview
Explore the profile of R R Bahnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naraghi R, Becich M, ODonnell W, Bahnson R
Urol Oncol
. 2011 Jan;
2(5):141-5.
PMID: 21224159
Our prospective study was designed to evaluate the routine use of frozen section of pelvic lymph node specimens prior to radical prostatectomy in patients with pre-biopsy prostate specific antigen (PSA)...
2.
Konety B, Painter L, Bahnson R
Urol Oncol
. 2011 Jan;
2(3):80-7.
PMID: 21224142
Health care costs from the management of prostate cancer are estimated at $1.5 billion per year. As the number of radical prostatectomies being performed increases, a simultaneous rise in these...
3.
Konety B, Naraghi R, Gooding W, ODonnell W, Bahnson R
Urol Oncol
. 2011 Jan;
2(1):14-9.
PMID: 21224130
We conducted a retrospective review of 345 patients who underwent radical prostatectomy between 1991 and 1994 to assess the overall accuracy, sensitivity, and specificity of computerized tomography (CT) for detection...
4.
M D P, Niemann T, Bahnson R
Urol Oncol
. 2001 May;
6(3):91-93.
PMID: 11343997
Purpose: To determine whether an extended sector biopsy of the prostate will increase the detection of prostate cancer, without causing an increase in morbidity. Materials and Methods: A total of...
5.
Bahnson R, Hanks G, Huben R, Kantoff P, Kozlowski J, Kuettel M, et al.
Oncology (Williston Park)
. 2001 Feb;
14(11A):111-9.
PMID: 11195405
Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements...
6.
7.
Baschinsky D, Chen J, Vadmal M, LUCAS J, Bahnson R, Niemann T
Arch Pathol Lab Med
. 2000 Aug;
124(8):1172-8.
PMID: 10923079
Objective: Carcinosarcomas of urinary bladder are rare malignant neoplasms. Seventy-eight cases have been previously described. The histologic composition of these tumors is variable, but diagnosis requires the presence of both...
8.
Brown D, Wagner T, Bahnson R
Urol Clin North Am
. 2000 Mar;
27(1):171-8, xi.
PMID: 10696256
With the introduction of BCG, intravesical instillation of immunotherapeutic agents has become a mainstay of therapy in the treatment of superficial bladder cancer. Interferon is capable of inducing a non-specific...
9.
Wagner 3rd T, Young D, Bahnson R
J Urol
. 1999 Mar;
161(4):1216-8.
PMID: 10081872
Purpose: For the treatment of clinically localized prostate cancer radical retropubic prostatectomy with its attendant hospital stay should be associated with higher charges than transperineal prostate brachytherapy. We report a...
10.
Baschinsky D, Niemann T, Maximo C, Bahnson R
Urology
. 1998 Jun;
51(5):840-5.
PMID: 9610606
Primary tumors of the seminal vesicle are rare; most reported cases are carcinomas, with occasional reports of primary seminal vesicle sarcoma and an uncommon group of mixed epithelial-stromal tumors. The...